Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
BioStem Technologies, Inc.
The company signed a major contract or deal. An 8-K is the notice a US public company must file within four business days of a major event.
Biostem TechnologiesAI Executive Summary
AI-powered analysis of 8-K filing content
BioStem Technologies completed a private placement on September 29, 2026, raising approximately $3.0 million by issuing 735,296 shares of common stock at $4.08 per share, along with Series A and Series B warrants. This funding strengthens the company's financial position to support operations and strategic growth initiatives.
Key Takeaways
BioStem raised $2,999,999.68 through private placement of 735,296 common shares at $4.08 per share
Investors received Series A and Series B warrants exercisable at $3.83 per share for up to 735,296 shares each
2 more takeaways
Filing Overview
What This Means
BioStem Technologies, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.